IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
ANC |
|
Anal canal carcinoma
|
|
|
0.736 |
0.385 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
TEC |
|
transient erythroblastopenia of childhood
|
|
|
0.659 |
0.577 |
ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
PSC |
|
Cholangitis, primary sclerosing
|
|
|
0.603 |
0.731 |
LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
IFNL4 |
K9M1U5
|
interferon lambda 4 (gene/pseudogene)
|
|
|
0.670 |
0.577 |
TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
AGRP |
O00253
|
agouti related neuropeptide
|
Signaling
|
7.0E-04 |
0.488 |
0.769 |
TNFRSF11B |
O00300
|
TNF receptor superfamily member 11b
|
|
0.16 |
0.422 |
0.808 |
CCL21 |
O00585
|
C-C motif chemokine ligand 21
|
Signaling
|
3.6E-02 |
0.502 |
0.769 |
NPC1 |
O15118
|
NPC intracellular cholesterol transporter 1
|
Transporter
|
6.5E-06 |
0.518 |
0.692 |
TLR3 |
O15455
|
toll like receptor 3
|
Receptor
|
1.6E-07 |
0.427 |
0.885 |
NDUFS4 |
O43181
|
NADH:ubiquinone oxidoreductase subunit S4
|
|
3.1E-04 |
0.587 |
0.808 |
AIRE |
O43918
|
autoimmune regulator
|
|
4.0E-12 |
0.516 |
0.808 |
SMARCA5 |
O60264
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
Enzyme
|
1.00 |
0.670 |
0.500 |